Magenta
is a Massachusetts-based biotechnology company that researches and develops stem cell-based therapeutics for the treatment of cancer, genetic and autoimmune diseases... Read moreMagenta
is a Massachusetts-based biotechnology company that researches and develops stem cell-based therapeutics for the treatment of cancer, genetic and autoimmune diseases... Read more
News
Mar 10, 2026
Owler
Magenta Therapeutics, Inc.: Magenta's employee count changed from 78 in Dec 2024 to 92 in Dec 2025
Sep 08, 2025
Investing.com
Magenta: Magenta Therapeutics receives Investment Bank Analyst Rating Update By Investing.com
Mar 12, 2025
Owler
Magenta Therapeutics, Inc.: Magenta's employee count changed from 53 in Mar 2024 to 78 in Dec 2024
Sep 11, 2023
Benzinga
Magenta: Magenta Therapeutics Announces Completion of Merger with Dianthus Therapeutics and Implementation of Reverse Stock Split
Aug 07, 2023
Business Wire
Press Release: Magenta : MAGENTA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Magenta Therapeutics, Inc. - MGTA
Aug 03, 2023
Marketscreener
Magenta: Magenta Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
May 12, 2023
PR-Inside
Press Release: Magenta : SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGTA, CTIC, ...
May 05, 2023
Medthority
Magenta: Magenta Therapeutics to merge with Dianthus Therapeutics and advance DNTH 103 complement inhibitor
May 04, 2023
Picante Today
Magenta: MAGENTA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Magenta Therapeutics, Inc. - MGTA
May 03, 2023
Endpoints News
Magenta: Magenta Therapeutics to merge with Dianthus in all-stock deal
Magenta Competitors
1
2
3
4
5
6
7
8
9
10